EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Elevated Sirtuin 1 Levels in Patients with Chronic Kidney Disease, Including on Peritoneal Dialysis: Associations with Cardiovascular Risk and Peritoneal Fibrosis

Angelika Bielach-Bazyluk iD, Katarzyna Czajkowska, Ewa Koc-Zorawska iD, Tomasz Hryszko iD, Edyta Zbroch iD

International Journal of Molecular Sciences · 2025

DOI: 10.3390/ijms26189033 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Angelika Bielach-Bazyluk und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology and Venereology, Medical University of Bialystok, 15-540 Bialystok, Poland. Hauptthemen laut MEDLINE: Sirtuin 1, Peritoneal Dialysis, Renal Insufficiency, Chronic, Cardiovascular Diseases. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 106 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Medical University of Bialystok, RPOWP 2007–2013 program, Priority I, Axis 1.1.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Sirtuin 1 (SIRT1) is implicated in oxidative stress, inflammation, and fibrosis—processes central to chronic kidney disease (CKD) and cardiovascular complications. Increased serum levels of SIRT1 have been reported in dialysis patients, and its role in peritoneal fibrosis, a leading cause of peritoneal dialysis failure, is well established. This study evaluated serum SIRT1 levels in 165 participants: peritoneally dialyzed patients (CAPD), conservatively treated CKD patients (CT), and healthy controls. Serum SIRT1 was measured by ELISA and analyzed alongside clinical factors. SIRT1 concentrations were markedly elevated in CAPD patients compared to both CT patients and controls. In CAPD patients, SIRT1 levels were not influenced by age, sex, dialysis adequacy, residual renal function, or comorbidities, but were higher in those with impaired left ventricular relaxation. Pharmacotherapy affected SIRT1 levels. Multivariate analysis identified phosphate and cholesterol as independent predictors of SIRT1. Our study suggests that serum SIRT1 levels may reflect diverse pathophysiological processes in CKD patients, including those on peritoneal dialysis. Elevated SIRT1 may indicate compensatory mechanisms related to renal dysfunction and cardiovascular stress. Future research on larger, pharmacologically homogeneous groups is warranted to clarify SIRT1’s role in peritoneal fibrosis and its potential as a biomarker of cardiovascular and renal complications in CKD.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Sirtuin 1Peritoneal DialysisRenal Insufficiency, ChronicCardiovascular DiseasesPeritoneal FibrosisHumansMaleFemaleMiddle AgedAgedBiomarkersAdultCase-Control StudiesRisk Factors

Stichwörter der Autor:innen

SIRT1cardiovascular diseasechronic kidney diseaseperitoneal dialysisperitoneal fibrosissirtuin 1

Substanzen

Sirtuin 1SIRT1 protein, humanBiomarkers

Autor:innen und Institutionen

  • Department of Dermatology and Venereology, Medical University of Bialystok, 15-540 Bialystok, Poland.
  • Second Department of Nephrology, Hypertension and Internal Medicine with Dialysis Unit, Medical University of Bialystok, 15-276 Bialystok, Poland.
  • Department of Internal Medicine and Hypertension, Medical University of Bialystok, 15-540 Bialystok, Poland.

ORCID-Profile: Angelika Bielach-Bazyluk, Ewa Koc-Zorawska, Tomasz Hryszko, Edyta Zbroch

Förderung

  • Medical University of Bialystok
  • RPOWP 2007–2013 program, Priority I, Axis 1.1

Zitieren

APA

Bielach-Bazyluk, A., Czajkowska, K., Koc-Zorawska, E., Hryszko, T., & Zbroch, E. (2025). Elevated Sirtuin 1 Levels in Patients with Chronic Kidney Disease, Including on Peritoneal Dialysis: Associations with Cardiovascular Risk and Peritoneal Fibrosis. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms26189033

Vancouver

Bielach-Bazyluk A, Czajkowska K, Koc-Zorawska E, Hryszko T, Zbroch E. Elevated Sirtuin 1 Levels in Patients with Chronic Kidney Disease, Including on Peritoneal Dialysis: Associations with Cardiovascular Risk and Peritoneal Fibrosis. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms26189033

BibTeX
@article{BielachBazyluk2025,
  author = {Bielach-Bazyluk, Angelika and Czajkowska, Katarzyna and Koc-Zorawska, Ewa and Hryszko, Tomasz and Zbroch, Edyta},
  title = {Elevated Sirtuin 1 Levels in Patients with Chronic Kidney Disease, Including on Peritoneal Dialysis: Associations with Cardiovascular Risk and Peritoneal Fibrosis},
  journal = {International Journal of Molecular Sciences},
  year = {2025},
  doi = {10.3390/ijms26189033}
}
Kostenlos starten →